EDITION:
- EU
- NA
The UK’s long and troubled CBD novel foods approval process seems to be gaining some momentum, as numerous major companies have announced their progression to the final risk assessment stage.
As the number of medicinal cannabis patients continues to rise here in Britain and internationally, a new charity, CannCare, has launched to uphold and champion the rights of those facing discrimination for consuming their prescribed medication.
Kingdom Therapeutics, a UK-Irish biotech company, has passed a ‘major milestone’ in its ambitious journey towards launching clinical trials into cannabis and Autism Spectrum Disorder (ASD)
VIST® Labs, LLC, a leading developer and manufacturer of cutting-edge cannabis purification and packaging solutions, is proud to announce a
The results of the German election are already having a ripple effect throughout the market, with the shift in attitudes towards cannabis reform making it a far riskier investment.
Business of Cannabis and Mary Jane are proud to announce that Boris Jordan, Chairman and CEO of Curaleaf, will be
Germany imported a record amount of cannabis in the final quarter of 2024, seeing imports more than double for the
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, is proud to announce its entry into
The Italian hemp industry has received unexpected support from the centre-right Forza Italia party, strengthening its position against an existential threat from the wider government.
The medical cannabis industry is in a precarious situation. The fledgling market is experiencing rapid growth across Europe, indicative of
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
